Advanced Gastrointestinal Endoscopic Imaging
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 3
- 试验地点
- 1
- 主要终点
- Number of Participants With Successful Imaging of the Mucosa
研究概览
简要总结
To develop new methods to detect malignant and premalignant conditions of the gastrointestinal tract.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients be at least 18 years of age,
- •Either genders
- •All ethnic backgrounds will be considered.
- •Patients who are scheduled for endoscopy by one of the investigators will be asked if they are interested in participating in the study.
- •The study will be open to all patients undergoing endoscopy that do not have exclusion criteria. We will ask all patients if they are participating in any other studies. If they are participating in any other study then we will ask them for more information to determine whether there could be any harm from participating in both studies and if there is then they will not be enrolled.
排除标准
- •Patients with unstable vital signs will not be included.
研究组 & 干预措施
endoscopy arm
imaging performed in conjunction with the regularly scheduled endoscopy during which the newer imaging techniques will be used to detect premalignant conditions. includes wide field fluorescence, microscopy, Raman spectroscopy and/or ultrasound.
干预措施: Dual axis endoscopic microscope (Device)
endoscopy arm
imaging performed in conjunction with the regularly scheduled endoscopy during which the newer imaging techniques will be used to detect premalignant conditions. includes wide field fluorescence, microscopy, Raman spectroscopy and/or ultrasound.
干预措施: wide field fluorescence system (Device)
endoscopy arm
imaging performed in conjunction with the regularly scheduled endoscopy during which the newer imaging techniques will be used to detect premalignant conditions. includes wide field fluorescence, microscopy, Raman spectroscopy and/or ultrasound.
干预措施: CellVizio (Device)
endoscopy arm
imaging performed in conjunction with the regularly scheduled endoscopy during which the newer imaging techniques will be used to detect premalignant conditions. includes wide field fluorescence, microscopy, Raman spectroscopy and/or ultrasound.
干预措施: fluorescent Peptide (Drug)
endoscopy arm
imaging performed in conjunction with the regularly scheduled endoscopy during which the newer imaging techniques will be used to detect premalignant conditions. includes wide field fluorescence, microscopy, Raman spectroscopy and/or ultrasound.
干预措施: fluorescein (Drug)
endoscopy arm
imaging performed in conjunction with the regularly scheduled endoscopy during which the newer imaging techniques will be used to detect premalignant conditions. includes wide field fluorescence, microscopy, Raman spectroscopy and/or ultrasound.
干预措施: indocyanine green (Drug)
结局指标
主要结局
Number of Participants With Successful Imaging of the Mucosa
时间窗: 5 years
Detection of mucosa abnormailities as a first step in the goal of detection of neoplasia
次要结局
未报告次要终点